| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |